e-learning
resources
Milan 2017
Sunday, 10.09.2017
ILDs: clinical problems
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interstitial lung abnormalities in smokers are associated with increased mortality
N. Hoyer (København S, Denmark)
Source:
International Congress 2017 – ILDs: clinical problems
Session:
ILDs: clinical problems
Session type:
Thematic Poster
Number:
862
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Hoyer (København S, Denmark). Interstitial lung abnormalities in smokers are associated with increased mortality. 862
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
The associations of interstitial lung abnormalities with cancer diagnoses and mortality
Source: Eur Respir J, 56 (6) 1902154; 10.1183/13993003.02154-2019
Year: 2020
Interstitial lung diseases, mortality and associated risk factors
Source: Eur Respir J 2004; 24: Suppl. 48, 667s
Year: 2004
Lymphopenia is linked to an increased incidence of cancer in smokers without COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Diaphragm dysfunction in combination with lung function decline is associated with higher mortality in idiopathic pulmonary fibrosis patients
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Weight loss as a predictor of mortality in patients with interstitial lung disease
Source: Eur Respir J, 52 (3) 1801289; 10.1183/13993003.01289-2018
Year: 2018
Risk factors associated with the development of interstitial lung abnormalities
Source: Eur Respir J, 58 (2) 2003005; 10.1183/13993003.03005-2020
Year: 2021
Associations between comorbidities and survival in patients with interstitial lung diseases
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Treatment and prognosis of lung cancer associated with interstitial pneumonia
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010
Overall survival is significantly higher in sarcoidosis than in IPF patients after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Smoking and interstitial lung diseases
Source: Eur Respir Rev 2015; 24: 428-435
Year: 2015
COPD and lung cancer incidence in never smokers
Source: International Congress 2019 – Asthma and COPD comorbidities
Year: 2019
High short-term mortality following lung biopsy for usual interstitial pneumonia
Source: Eur Respir J 2001; 17: 175-179
Year: 2001
Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018
Biomarkers in pulmonary hypertension associated to interstitial lung disease
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Increased relative mortality in women with severe oxygen-dependent COPD
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010
Markers of systemic inflammation are associated with increased symptoms and respiratory exacerbations among smokers with preserved spirometry in SPIROMICS
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018
Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
Source: Eur Respir J 2016; 47:1365-1373
Year: 2016
Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality
Source: Eur Respir J 2010; 35: 1303-1311
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept